Cargando…

Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance

BACKGROUND: Olanzapine use has been reported during pregnancy and breastfeeding, but there are no controlled clinical trials assessing the safety of olanzapine exposure to infants and fetuses. The purpose of this report was to review and analyze prospective post-marketing cases of pregnancy and brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunner, Elizabeth, Falk, Deborah M, Jones, Meghan, Dey, Debashish K, Shatapathy, Chetan Chinmaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750520/ https://www.ncbi.nlm.nih.gov/pubmed/23902726 http://dx.doi.org/10.1186/2050-6511-14-38

Ejemplares similares

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database
por: Jones, Meghan E., et al.
Publicado: (2013)

Risk of Mortality (Including Sudden Cardiac Death) and Major Cardiovascular Events in Atypical and Typical Antipsychotic Users: A Study with the General Practice Research Database
por: Murray-Thomas, Tarita, et al.
Publicado: (2013)

Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework
por: Renaud, Françoise, et al.
Publicado: (2022)

Safety surveillance for PrEP in pregnant and breastfeeding women
por: Fairlie, Lee, et al.
Publicado: (2023)

Safety profile and adverse effects of use of olanzapine in pregnancy: A report of two cases
por: Sahoo, Manoj K., et al.
Publicado: (2022)

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study
por: Meyers, Kristin J., et al.
Publicado: (2017)

Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
por: Brunner, Elizabeth, et al.
Publicado: (2014)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis
por: Rezaallah, Bita, et al.
Publicado: (2019)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding
por: Cavalcante, Marcelo Borges, et al.
Publicado: (2021)

Pregnancy, Breastfeeding, and Vitamin D
por: Durá-Travé, Teodoro, et al.
Publicado: (2023)

Olanzapine use in a manic patient during second and third trimester pregnancy
por: Choi, Lynn, et al.
Publicado: (2014)

Olanzapine Induced Hyponatraemia
por: Dudeja, Sonia J, et al.
Publicado: (2010)

Olanzapine-Induced Neutropenia
por: Malhotra, Kirti, et al.
Publicado: (2015)

Olanzapine-induced Psoriasis
por: Chepure, Ashish Hanmantrao, et al.
Publicado: (2017)

Seizure associated with olanzapine
por: Uvais, N. A., et al.
Publicado: (2018)

Correction: Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis
por: Rezaallah, Bita, et al.
Publicado: (2020)

Global trends in exclusive breastfeeding
por: Cai, Xiaodong, et al.
Publicado: (2012)

Duloxetine and Pregnancy Outcomes: Safety Surveillance Findings
por: Hoog, Sharon L, et al.
Publicado: (2013)

Monkeypox and pregnancy: time for global surveillance and prevention strategies
por: Khalil, Asma, et al.
Publicado: (2022)

Running Habits of Competitive Runners During Pregnancy and Breastfeeding
por: Tenforde, Adam S., et al.
Publicado: (2015)

The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy
por: Eghbali, Aziz, et al.
Publicado: (2023)

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
por: Ifteni, Petru, et al.
Publicado: (2014)

Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance Data
por: Newman, Lori, et al.
Publicado: (2013)

Breastfeeding: Nature’s Safety Net
por: Agarwal, Manisha, et al.
Publicado: (2012)

Olanzapine-induced acute necrotising pancreatitis leading to recurrent multiple organ dysfunction syndrome
por: Naxakis, Stelios, et al.
Publicado: (2022)

Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
por: Jones, Meghan E., et al.
Publicado: (2015)

Hypertensive disorders of pregnancy and breastfeeding practices: A secondary analysis of data from the All Our Families Cohort
por: Horsley, Kristin, et al.
Publicado: (2022)

Hyperglycemia associated with olanzapine treatment
por: Kumar, P. N. Suresh, et al.
Publicado: (2011)

Olanzapine induced tardive dystonia
por: Aggarwal, Ashish, et al.
Publicado: (2008)

Treatment of Delusional Infestation with Olanzapine
por: Kansal, Naveen Kumar, et al.
Publicado: (2012)

Characterization of Olanzapine-Solid Dispersions
por: Krishnamoorthy, Venkateskumar, et al.
Publicado: (2011)

Olanzapine-induced Orthostatic Hypotension
por: Jana, Amlan Kusum, et al.
Publicado: (2015)

Olanzapine-induced eosinophilic pleuritis
por: Evison, Matthew, et al.
Publicado: (2014)

Emphysematous pancreatitis predisposed by Olanzapine
por: Samanta, Sukhen, et al.
Publicado: (2014)

Olanzapine-induced Skin Eruptions
por: Chawla, Nishtha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_94794s6duo8gr2uppi1nlhfrr9